Audit of Invasive Cervical Cancers
Published December 2006 | ISBN 978 1 84463 040 0
Because cervical screening has never been subjected to the randomised controlled trials that are today's gold standard, questions about its effectiveness can only be answered by auditing the programme. Audit yields useful information which allows the promotion of good practice and may identify areas where further attention is needed.
The aim of this publication is to define a national protocol for audit of cases of invasive cervical cancer in order that standardised data can be pooled and analysed meaningfully.
PDFs available for download
Section A (1) (PDF 17Kb) |
NHSCSP28: Appendix 1 (PDF 152Kb) |
- NHSCSP home page
- Programme publications
- About cervical screening
- Human Papilloma Virus (HPV)
- Research in cervical screening
- More information about the
screening programme- Information about cervical cancer
- Diethylstilbestrol (DES) exposed women
- Liquid Based Cytology (LBC)
- LBC implementation guidance
- Who does what in the programme
- Quality Assurance
- Use of patient information
- Cervical cytology training centres
- Human Papilloma virus (HPV)
- HPV triage and test of cure protocol
- HMR101 Request/Report Form
- 14 day turnaround time
- Frequently asked questions
- Programme statistics
- Programme news index
- Useful links
